Leadership
QB3 leadership at the three campuses and the central administration.
Faculty Leaders
 |
Regis B. Kelly, Ph.D. QB3 Director Regis B. Kelly is a distinguished neuroscientist and former executive vice chancellor of UCSF (from October, 2001 until January 31, 2004). As executive vice chancellor, Kelly oversaw the UCSF research enterprise, which now totals about $465 million annually. He also forged new research ties between the university and private industry. Kelly directs the institute at its headquarters on UCSF's Mission Bay campus and also maintains a Berkeley office. |
 |
David Haussler, Ph.D. QB3-Santa Cruz Director David Haussler holds a UC Presidential Chair in Computer Science, is Director of the Center for Biomolecular Science & Engineering at UC Santa Cruz, and is a Howard Hughes Medical Institute (HHMI) Investigator. He earned his undergraduate degree in Mathematics from Connecticut College, and his Ph.D. in Computer Science from University of Colorado at Boulder. David Haussler's webpage |
 |
Susan Marqusee, M.D., Ph.D. QB3-Berkeley Director Susan Marqusee is Professor of Molecular and Cell Biology, Division of Biochemistry and Molecular Biology. She received her A.B. in Physics and Chemistry from Cornell University in 1982, and her M.D. and Ph.D. degrees from Stanford University in 1990. After a post-doctoral fellowship at MIT, she joined the UC Berkeley faculty as Assistant Professor in 1992, advancing to Associate and Full Professor in 1998 and 2001 respectively. Susan Marqusee's webpage |
 |
Andrej Sali, Ph.D. QB3-UCSF Director Andrej Sali is a Professor in the Department of Bioengineering and Therapeutic Sciences. He received his B.Sc. in Chemistry from the University of Ljubljana, Slovenia, and his Ph.D. in Molecular Biophysics from the University of London, UK. Andrej Sali's webpage |
 |
Marc A. Shuman, M.D. QB3 Clinical Director Marc Shuman is Professor of Medicine and Leader of the Prostate Cancer Program at UC San Francisco. As Clinical Director for QB3, Shuman will catalyze and facilitate collaborations between clinical and basic scientists in QB3. He earned his M.D. from Thomas Jefferson Medical College in Philadelphia in 1967. Marc Shuman's webpage |
Central Administration
 |
Douglas Crawford, Ph.D. Associate Director Douglas Crawford created and manages the QB3 Garage@UCSF and the QB3 Mission Bay Incubator Network, which have helped launch 22 companies. He is a founder and the managing director of Mission Bay Capital. Crawford acts as a Knowledge Broker between the QB3 campuses and the bio-pharmaceutical industry. He is also a board member of Pacific BioPharma (observer), BayBio Institute, and BioE2E; and chair of the UCSF Clinical and Translational Sciences Institute Virtual Home program. Crawford received his Ph.D. in biochemistry at UCSF. |
 |
Tracy Saxton, Ph.D. Alliance Management Director Tracy Saxton manages the UC-Pfizer alliance. Prior to joining QB3 in 2008, Saxton held positions at Bay Area biotechnology companies Tularik/Amgen, Threshold Pharmaceuticals, and Geron Corporation. She began her diverse career as a drug discovery scientist, and moved to leadership roles in global regulatory affairs, clinical development, business development and project management. She obtained her Ph.D. in molecular genetics from the University of Toronto. |
Follow us on Twitter